Top five employment considerations for early-stage and spin-out biotech companies
In this second article of our three-part series - Thinking early: key legal points for early-stage biotech companies - we cover the...
Podcast: Early-stage funding for FemTech companies in the UK
The FemTech sector, which focuses on technology for women’s health and wellness, is experiencing rapid growth in the UK. Out of the 540...
Top five corporate and tax considerations for early-stage and spin-out biotech companies
In this first article of our three-part series - Thinking early: key legal points for early-stage biotech companies - we focus on the key...
Genesis 2025: Maximising returns from life science innovation
Louisa Jacobs and Oliver Alsop attended this year’s One Nucleus Genesis conference, which brought together industry, investors,...
Sanofi & Regeneron v Amgen - 7 Takeaways from the UPC Court of Appeal
On 25 November 2025, the UPC Court of Appeal (CoA) handed down one of its most significant decisions to date on the UPC’s application of...
As a free user, you can like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net